Gatuzosiran (sodium)
Gatuzosiran sodium, a siRNA, is a 17-beta-hydroxysteroid dehydrogenase 13 (HSD17B13) synthesis reducer. It is used for the study of fatty liver disease.
Product Specifications
UNSPSC
12352208
Target
17β-HSD
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Smiles
[Gatuzosiran(sodium)]
Molecular Formula
C493H609F11N163Na44O311P43S7
Molecular Weight
16570.80
References & Citations
[1]WHO Drug Information - Vol. 38 , No. 4, 2024
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15163592 1 Vial
Lentiviral mouse Itga10 shRNA (UAS) - Lentiviral mouseItga10 shRNA (UAS, GFP) (25)
Ask
View Details 
MBS7241215-01 48 Well
Monkey BTB/POZ domain-containing protein KCTD18 (KCTD18) ELISA Kit
Ask
View Details 
MBS7241215-02 96 Well
Monkey BTB/POZ domain-containing protein KCTD18 (KCTD18) ELISA Kit
Ask
View Details MBS7241215-03 5x 96 Well
Monkey BTB/POZ domain-containing protein KCTD18 (KCTD18) ELISA Kit
Ask
View Details MBS7241215-04 10x 96 Well
Monkey BTB/POZ domain-containing protein KCTD18 (KCTD18) ELISA Kit
Ask
View Details